Diabetes mellitus (DM) imposes a group of common metabolic irregularities that share the phenotype of hyperglycemia (
1) associated with microvascular complications (
2) including atherosclerosis (
3,
4) and coronary artery disease (
3). The relationship between metabolic control and development of chronic adverse complications in type 1 diabetes (T1D) has always been a great concern over the years, and nowadays the main indicator of long-term glycemic control in T1D and its complications is glycosylated hemoglobin (HbA1c) (
5). Although elevated baseline, mean or updated mean of HbA1c levels have been correlated with diabetic complications (reviewed in (
6)), actually several studies have introduced some biomarkers of inflammation and endothelial dysfunction in T1D with or without microvascular complications or diabetic nephropathy (
7-
9).
YKL-40, also called human cartilage glycoprotein-39 or chitinase 3-like-1(CHI3L1) (
10), is a member of mammalian chitinase-like proteins binding to lectin without chitinase activity (
11). YKL-40 is secreted by different human cells including inflammatory cells such as neutrophils (
12) and macrophages (
13). A substantial body of evidence indicates that YKL-40, as an inflammatory marker in different pathologies (
14-
17), participates in diabetes as well as its complications including endothelial dysfunction (
13), atherosclerosis (
18), cardiovascular disease (
19,
20), and albuminuria (
19).
Considering that there are little studies on the correlation of YKL-40 with HbA1C and diabetic nephropathy in T1D (
19), we evaluated such correlation to suggest YKL-40 as both diagnostic and prognostic marker of T1D metabolic control as well as of diabetic nephropathy.